Results for tag: "Fetzima"

Fetzima is a medication used to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). It is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) that works by increasing the levels of serotonin and norepinephrine in the brain. Fetzima is available in both capsule and tablet form and is taken orally once daily. It is typically prescribed for adults 18 years and older. Fetzima is a relatively new medication on the market, having been approved by the U.S. Food and Drug Administration (FDA) in 2013. It is marketed by Allergan, a global pharmaceutical company. Other companies in the market include Sunovion Pharmaceuticals, Inc., which markets Fetzima under the brand name Fetzima XR, and Lupin Pharmaceuticals, Inc., which markets Fetzima under the brand name Fetzima ER. Show Less Read more